Each year carcinoma of the breast affects more than 175,000 women in t
he United States. The majority of these cases are stage I or II breast
cancer. Local therapy combined with systemic adjuvant therapy frees t
hese patients of disease and provides many with long-term survival. Ap
proximately 25% of all breast cancer patients develop their malignancy
while premenopausal-during their childbearing years.(2) Breast cancer
is the second most common malignancy during pregnancy, occurring in 1
0 to 30 patients per 100,000 pregnancies. The current trend in the Uni
ted States of delaying pregnancy until a later age may increase the pr
oportion of women who develop breast cancer during pregnancy. An indiv
idual clinician's experience with gestational breast cancer is usually
limited to a handful of cases. Unfortunately, the management strategy
is often rooted in obsolete teachings and philosophies. In 1880, Samu
el Gross stated that the growth of gestational breast cancer was rapid
and its course excessively malignant. Haagensen and Stout(5) declared
in 1943 that no patient with breast cancer diagnosed during pregnancy
should undergo surgery because these cases were incurable. A survey b
y Saunders and Baum(8) revealed that general practitioners and general
surgeons thought pregnancy conferred a worse prognosis. The reasons i
ncluded excess inflammatory breast carcinoma, hormonal changes of preg
nancies, inherent aggressiveness of these tumors, and relative youth o
f the patients. None thought diagnostic delay contributed to the poor
prognosis of these patients. In contrast, obstetricians did not believ
e these patients did worse, and they did not believe therapeutic abort
ion was mandatory. Opinions varied concerning subsequent preg- nancy,
the effect of chemotherapy on fertility, and abortion. Thus, the idea
appears widespread that breast cancer in a pregnant woman is in some w
ay a different disease from breast cancer in a nonpregnant woman. This
attitude has abated, and it has been shown that the outcome in patien
ts with concurrent breast cancer and pregnancy is the same as in their
nonpregnant counterparts when matched for age and stage of disease.(9
) Yet a woman diagnosed with breast cancer during pregnancy or lactati
on is more Likely to fare worse than a woman of a similar age who is n
ot pregnant. Why should this be so?